Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Breast Neoplasms 20 Stomach Neoplasms 2 Inflammatory Breast Neoplasms 2 Rectal Neoplasms 1 Neoplastic Cells, Circulating 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Invasive Breast Cancer 1 HER2 Positive Breast Cancer 1 Elderly Metastatic Breast Cancer Population 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiotoxicity 1 Breast Neoplasms, Male 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Cancer 1

Interventions

Etoposide 5 Rituximab 4 Radiotherapy 4 Methotrexate 4 Cytarabine 4 Cyclophosphamide 3 Cisplatin 3 Vincristine 2 Specimen Handling 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methylprednisolone 2 Gemcitabine 2 Fenretinide 2 Doxorubicin 2 Carmustine 2 venetoclax 1 tucatinib 1 temsirolimus 1 plerixafor 1 pertuzumab 1 palbociclib 1 olaparib 1 merphos 1 liposomal amphotericin B 1 ixabepilone 1 ibrutinib 1 ibritumomab tiuxetan 1 fludarabine 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Lymphoma, Non-Hodgkin × Trastuzumab × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡